Dr. Reddy's Laboratories Ltd Company Profile (NYSE:RDY)

About Dr. Reddy's Laboratories Ltd (NYSE:RDY)

Dr. ReddyDr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NYSE:RDY
  • CUSIP: N/A
  • Web: www.drreddys.com
Capitalization:
  • Market Cap: $6.25367 billion
  • Outstanding Shares: 165,801,000
Average Prices:
  • 50 Day Moving Avg: $32.97
  • 200 Day Moving Avg: $38.79
  • 52 Week Range: $29.83 - $50.10
P/E:
  • Trailing P/E Ratio: 35.10
  • Foreward P/E Ratio: 19.02
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.2 billion
  • Price / Sales: 2.84
  • Book Value: $11.66 per share
  • Price / Book: 3.23
Dividend:
  • Annual Dividend: $0.29
  • Dividend Yield: 0.8%
Profitability:
  • EBIDTA: $386.11 million
  • Net Margins: 7.92%
  • Return on Equity: 9.27%
  • Return on Assets: 5.06%
Debt:
  • Debt-to-Equity Ratio: 0.20%
  • Current Ratio: 1.53%
  • Quick Ratio: 1.10%
Misc:
  • Average Volume: 341,920 shs.
  • Beta: 0.34
  • Short Ratio: 12.2
 

Frequently Asked Questions for Dr. Reddy's Laboratories Ltd (NYSE:RDY)

What is Dr. Reddy's Laboratories Ltd's stock symbol?

Dr. Reddy's Laboratories Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "RDY."

How often does Dr. Reddy's Laboratories Ltd pay dividends? What is the dividend yield for Dr. Reddy's Laboratories Ltd?

Dr. Reddy's Laboratories Ltd declared a None dividend on Friday, August 4th. Investors of record on Monday, July 17th will be paid a dividend of $0.294 per share on Thursday, August 10th. The ex-dividend date is Thursday, July 13th. View Dr. Reddy's Laboratories Ltd's Dividend History.

How were Dr. Reddy's Laboratories Ltd's earnings last quarter?

Dr. Reddy's Laboratories Ltd (NYSE:RDY) issued its earnings results on Tuesday, July, 26th. The company reported $0.00 earnings per share (EPS) for the quarter. The company earned $479 million during the quarter, compared to analyst estimates of $557 million. Dr. Reddy's Laboratories Ltd had a net margin of 7.92% and a return on equity of 9.27%. View Dr. Reddy's Laboratories Ltd's Earnings History.

When will Dr. Reddy's Laboratories Ltd make its next earnings announcement?

Dr. Reddy's Laboratories Ltd is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Dr. Reddy's Laboratories Ltd.

Where is Dr. Reddy's Laboratories Ltd's stock going? Where will Dr. Reddy's Laboratories Ltd's stock price be in 2017?

4 brokers have issued 12 month price objectives for Dr. Reddy's Laboratories Ltd's stock. Their predictions range from $31.62 to $31.62. On average, they expect Dr. Reddy's Laboratories Ltd's share price to reach $31.62 in the next twelve months. View Analyst Ratings for Dr. Reddy's Laboratories Ltd.

Who are some of Dr. Reddy's Laboratories Ltd's key competitors?

Who are Dr. Reddy's Laboratories Ltd's key executives?

Dr. Reddy's Laboratories Ltd's management team includes the folowing people:

  • Satish K. Reddy, Chairman of the Board
  • G. V. Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
  • Saumen Chakraborty, President, Chief Financial Officer, Global Head - HR and IT & BPE
  • Sripada Chandrasekhar Ph.D., President, Global Head - Human Resources
  • Abhijit Mukherjee, Chief Operating Officer
  • Amit Biswas, Executive Vice President and Head - Integrated Product Development
  • Raghav Chari, Executive Vice President and Head - Proprietary Products
  • Samiran Das, Executive Vice President and Head - Global Manufacturing Operations
  • M. V. Ramana, Executive Vice President and Head-Branded Markets - India & Emerging Markets
  • Cartikeya Reddy, Executive Vice President and Head-Biologics

Who owns Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock is owned by many different of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (3.38%), Royal Bank of Canada (2.09%), Commonwealth Bank of Australia (2.08%), Vanguard Group Inc. (0.89%), State Street Corp (0.38%) and Dimensional Fund Advisors LP (0.35%). View Institutional Ownership Trends for Dr. Reddy's Laboratories Ltd.

Who sold Dr. Reddy's Laboratories Ltd stock? Who is selling Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., JPMorgan Chase & Co., US Bancorp DE, LMR Partners LLP, Acadian Asset Management LLC, Russell Investments Group Ltd., OxFORD Asset Management LLP and Schroder Investment Management Group. View Insider Buying and Selling for Dr. Reddy's Laboratories Ltd.

Who bought Dr. Reddy's Laboratories Ltd stock? Who is buying Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock was purchased by a variety of institutional investors in the last quarter, including Royal Bank of Canada, First Trust Advisors LP, Commonwealth Bank of Australia, State Street Corp, Prudential Financial Inc., Segantii Capital Management Ltd, Fisher Asset Management LLC and Mitsubishi UFJ Trust & Banking Corp. View Insider Buying and Selling for Dr. Reddy's Laboratories Ltd.

How do I buy Dr. Reddy's Laboratories Ltd stock?

Shares of Dr. Reddy's Laboratories Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dr. Reddy's Laboratories Ltd's stock price today?

One share of Dr. Reddy's Laboratories Ltd stock can currently be purchased for approximately $37.66.


MarketBeat Community Rating for Dr. Reddy's Laboratories Ltd (NYSE RDY)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  228
MarketBeat's community ratings are surveys of what our community members think about Dr. Reddy's Laboratories Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Dr. Reddy's Laboratories Ltd (NYSE:RDY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $31.62 (16.04% downside)

Analysts' Ratings History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/21/2017Morgan StanleyUpgradeEqual Weight -> OverweightLowView Rating Details
9/3/2017Jefferies Group LLCReiterated RatingSell$31.62MediumView Rating Details
8/31/2017CLSAUpgradeUnderperform -> OutperformHighView Rating Details
5/15/2017Deutsche Bank AGUpgradeSell -> HoldHighView Rating Details
7/27/2016HSBC Holdings plcDowngradeHold -> ReduceN/AView Rating Details
7/26/2016Credit Suisse GroupDowngradeNeutral -> UnderperformN/AView Rating Details
5/2/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutralN/AView Rating Details
11/10/2015Citigroup Inc.DowngradeBuy -> NeutralN/AView Rating Details
11/6/2015Barclays PLCDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Earnings by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)
Earnings History by Quarter for Dr. Reddy's Laboratories Ltd (NYSE RDY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017        
7/26/2016Q117$0.00$557.00 million$479.00 millionViewListenView Earnings Details
5/12/2016Q416$0.07$2.41 billion$567.00 billionViewListenView Earnings Details
2/9/2016Q316$0.51$2.48 million$599.00 millionViewN/AView Earnings Details
10/29/2015Q116$0.65$2.54 billion$609.00 millionViewListenView Earnings Details
5/12/2015Q415$0.49$559.00 million$621.00 millionViewListenView Earnings Details
1/29/2015Q315$0.53$561.00 million$610.00 millionViewN/AView Earnings Details
7/30/2014Q115$0.54$474.00 million$486.00 millionViewN/AView Earnings Details
5/13/2014Q414$0.52$0.47$557.00 million$580.00 millionViewN/AView Earnings Details
2/11/2014Q314$0.45$0.59$558.20 million$571.00 millionViewN/AView Earnings Details
10/31/2013Q214$0.46$0.65$561.00 million$537.00 millionViewN/AView Earnings Details
7/30/2013Q413$0.43$0.40$551.40 million$478.00 millionViewN/AView Earnings Details
5/14/2013$0.60ViewN/AView Earnings Details
2/14/2013Q313$0.40$505.00 million$522.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Current Year EPS Consensus Estimate: $1.28 EPS
Next Year EPS Consensus Estimate: $1.98 EPS

Dividends

Current Dividend Information for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Most Recent Dividend:8/10/2017
Annual Dividend:$0.29
Dividend Yield:0.77%
Dividend Growth:7.40% (3 Year Average)
Payout Ratio:27.88% (Trailing 12 Months of Earnings)
22.66% (Based on This Year's Estimates)
14.65% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)

Dividend History by Quarter for Dr. Reddy's Laboratories Ltd (NYSE RDY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2017None$0.297/13/20177/17/20178/10/2017
6/6/2017$0.297/13/20177/17/20177/17/2017
6/6/2016Annual$0.287/14/20167/18/20167/18/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Latest Headlines for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Source:
DateHeadline
finance.yahoo.com logoDR. REDDY'S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)
finance.yahoo.com - September 23 at 2:01 AM
nasdaq.com logoHealth Care Sector Update for 09/21/2017: RDY,AKTX,RWLK - Nasdaq
www.nasdaq.com - September 22 at 9:00 PM
globenewswire.com logoDR. REDDY ALERT: Rosen Law Firm Reminds Dr. Reddy's Laboratories Ltd. Investors of Important Deadline in First ... - GlobeNewswire (press release)
www.globenewswire.com - September 22 at 9:00 PM
nasdaq.com logoDr. Reddy's Laboratories (RDY) Surges: Stock Moves 5.7% Higher - Nasdaq
www.nasdaq.com - September 22 at 9:00 PM
finance.yahoo.com logoDR. REDDY ALERT: Rosen Law Firm Reminds Dr. Reddy’s Laboratories Ltd. Investors of Important Deadline in First Filed Class Action – RDY
finance.yahoo.com - September 22 at 9:00 PM
feeds.benzinga.com logoDR. REDDY ALERT: Rosen Law Firm Reminds Dr. Reddy's Laboratories Ltd. Investors of Important Deadline in First Filed Class Action – RDY
feeds.benzinga.com - September 22 at 7:25 PM
finance.yahoo.com logoRDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 22 at 3:55 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 22 at 3:55 PM
americanbankingnews.com logoDr. Reddy's Laboratories Ltd (RDY) Upgraded to Overweight by Morgan Stanley
www.americanbankingnews.com - September 21 at 11:28 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline - October 24, 2017
finance.yahoo.com - September 20 at 8:15 AM
finance.yahoo.com logoScott+Scott, Attorneys at Law, LLP Reminds Investors of October 24th Lead Plaintiff Deadline in Securities Class Action Against Dr. Reddy’s Laboratories Limited (RDY)
finance.yahoo.com - September 20 at 8:15 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy's Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY
finance.yahoo.com - September 20 at 8:15 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 20 at 8:15 AM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Dr. Reddy’s Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 19 at 7:05 AM
americanbankingnews.com logoComparing Dr. Reddy's Laboratories (RDY) and Its Peers
www.americanbankingnews.com - September 18 at 4:30 PM
businesswire.com logoRDY EQUITY ALERT: The Law Offices of Vincent Wong Reminds ... - Business Wire (press release)
www.businesswire.com - September 16 at 1:37 AM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 16 at 1:36 AM
benzinga.com logoMid-Afternoon Market Update: Dow Rises Over 50 Points; T2 Biosystems Shares Plummet - Benzinga
www.benzinga.com - September 15 at 3:30 PM
finance.yahoo.com logoRDY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 15 at 3:30 PM
businesswire.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy’s Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October ...
www.businesswire.com - September 15 at 8:04 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy’s Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 15 at 8:04 AM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 15 at 8:04 AM
streetinsider.com logoForm 6-K DR REDDYS LABORATORIES For: Sep 13 - StreetInsider.com
www.streetinsider.com - September 13 at 3:36 PM
businesswire.com logoRDY INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Dr. Reddy's ... - Business Wire (press release)
www.businesswire.com - September 13 at 3:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline - October 24, 2017
finance.yahoo.com - September 13 at 3:35 PM
finance.yahoo.com logoThe Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Dr. Reddy’s Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 13 at 3:35 PM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 13 at 3:35 PM
finance.yahoo.com logoThe Klein Law Firm Announces a Class Action Filed on Behalf of Dr. Reddy’s Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017 (RDY)
finance.yahoo.com - September 13 at 8:19 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 13 at 8:19 AM
finance.yahoo.com logoRDY INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 12 at 9:09 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 12 at 9:08 AM
finance.yahoo.com logoRDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 9 at 7:50 AM
finance.yahoo.com logoGlancy Prongay & Murray LLP Continues Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors
finance.yahoo.com - September 9 at 7:50 AM
finance.yahoo.com logoDR. REDDY’S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)
finance.yahoo.com - September 9 at 7:50 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Dr. Reddy’s Laboratories Ltd. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit
finance.yahoo.com - September 9 at 7:50 AM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 9 at 7:50 AM
feeds.benzinga.com logoDR. REDDY'S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. – (RDY)
feeds.benzinga.com - September 8 at 11:57 PM
feeds.benzinga.com logoRDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017
feeds.benzinga.com - September 8 at 3:41 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy’s Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - September 8 at 7:36 AM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 8 at 7:36 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy’s Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017
finance.yahoo.com - September 8 at 7:36 AM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 8 at 7:36 AM
finance.yahoo.com logoFeatured Company News - Dr. Reddy's Labs Announces the Launch of Anti-Depressant and Muscle Relaxant Tablets in the US
finance.yahoo.com - September 8 at 7:36 AM
feeds.benzinga.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
feeds.benzinga.com - September 7 at 6:54 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 7 at 8:16 AM
globenewswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy's Laboratories Ltd. of a Class ... - GlobeNewswire (press release)
globenewswire.com - September 6 at 7:32 AM
rttnews.com logoDr. Reddy's Laboratories (RDY) Jumped After Court Ruling
www.rttnews.com - September 5 at 5:47 AM
americanbankingnews.com logoDr. Reddy's Laboratories' (RDY) "Sell" Rating Reaffirmed at Jefferies Group LLC
www.americanbankingnews.com - September 3 at 7:58 AM
businesswire.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Dr. Reddy's ... - Business Wire (press release)
www.businesswire.com - September 3 at 6:12 AM
americanbankingnews.com logoDr. Reddy's Laboratories Ltd (RDY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 3 at 2:32 AM

Social

Chart

Dr. Reddy's Laboratories Ltd (RDY) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff